![Pierre Miniou](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Positionen von Pierre Miniou
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Inflectis Bioscience SAS
![]() Inflectis Bioscience SAS BiotechnologyHealth Technology Inflectis Bioscience SAS develops therapeutics for the treatment of protein misfolding diseases. The firm engages in the development of new chemical series for the treatment of non-orphan diseases whose etiology also lies in the accumulation of misfolded proteins. The company was founded in September 2013 by Philippe Guedat and Pierre Miniou and is headquartered in Nantes, France. | Direktor/Vorstandsmitglied | 01.09.2013 | - |
Geschäftsführer | 01.09.2013 | - | |
Gründer | 01.09.2013 | - | |
Corporate Officer/Principal | 01.09.2013 | - |
Karriereverlauf von Pierre Miniou
Ehemalige bekannte Positionen von Pierre Miniou
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Vivalis SA
![]() Vivalis SA Pharmaceuticals: OtherHealth Technology Vivalis SA manufactures human and animal vaccines. The firm specializes in the research and development of vaccines and antiviral molecules, as well as in recombinant therapeutic protein and monoclonal antibody expression systems development. The firm's embryonic stem cells are used for practical applications in human and animal health. It also helps its clients in a case by case basis for the development of processes in the frame of service agreement. The company was founded in April 1999 and is headquartered in France. | Corporate Officer/Principal | 16.07.2010 | 28.05.2013 |
Statistik
International
Frankreich | 3 |
Operativ
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Chief Operating Officer | 1 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Vivalis SA
![]() Vivalis SA Pharmaceuticals: OtherHealth Technology Vivalis SA manufactures human and animal vaccines. The firm specializes in the research and development of vaccines and antiviral molecules, as well as in recombinant therapeutic protein and monoclonal antibody expression systems development. The firm's embryonic stem cells are used for practical applications in human and animal health. It also helps its clients in a case by case basis for the development of processes in the frame of service agreement. The company was founded in April 1999 and is headquartered in France. | Health Technology |
Inflectis Bioscience SAS
![]() Inflectis Bioscience SAS BiotechnologyHealth Technology Inflectis Bioscience SAS develops therapeutics for the treatment of protein misfolding diseases. The firm engages in the development of new chemical series for the treatment of non-orphan diseases whose etiology also lies in the accumulation of misfolded proteins. The company was founded in September 2013 by Philippe Guedat and Pierre Miniou and is headquartered in Nantes, France. | Health Technology |
- Börse
- Insiders
- Pierre Miniou
- Erfahrung